Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Juan J Rojas

3PUBLICATIONS

9CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityProteins and peptides

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jan 05, 2024

Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors.

M Costa-Garcia, J J Rojas, M D Ramos

|Jul 29, 2023

Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice.

Martin C Langenmayer, Anna-Theresa Luelf-Averhoff, Lisa Marr

|Apr 04, 2023

Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease.

Stephanie Riederer, Ana Del Canizo, Javier Navas

Pageof 1

Frequent Collaborators

2 joint publications

Gerd Sutter

1 joint publications

M Costa-Garcia

1 joint publications

P Barlabé

1 joint publications

R Alemany

1 joint publications

R Moreno

1 joint publications

Marlowe G Peter

1 joint publications

Martin C Langenmayer

1 joint publications

Alina Tscherne

1 joint publications

Robert Fux

Frequent Collaborators

2 joint publications

Gerd Sutter

1 joint publications

M Costa-Garcia

1 joint publications

P Barlabé

1 joint publications

R Alemany

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on : Jan 15, 2020

See more related videos

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on : Jan 15, 2020

See more related videos